INSECTICID Insecticides (India) Q3 FY25 results (Oct–Dec 2024) and concall
Insecticides India Limited reported its highest-ever PAT of INR128 crores for 9M FY25, driven by a successful premiumization strategy with premium products contributing 62% to B2C sales. Q3 FY25 saw robust EBITDA and PAT growth despite being a lean quarter with some impact on B2B sales. The company is investing significantly in capex for new plants and R&D, targeting continued growth in premium products and exports, alongside improvements in working capital and organizational strength.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 627 | 358 |
| EBITDA | 90 | 31 |
| Net profit | 61 | 17 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
